Introduction. Several studies identified allergic contact dermatitis (ACD) as the most common cause of periorbital dermatitis. Nevertheless, there is paucity of studies directly comparing the relevance of allergens in the eyelid dermatitis versus non eyelid dermatitis populations. Methods. 1043 patients who presented with the clinical suspicion of ACD were patch tested in a 2-year period. Patient demographics, clinical features, history of atopy and results of patch tests were collected. Patch test results of patients with eyelid dermatitis were compared with those of patients with dermatitis confined to other body areas. Results. 191 out of 1043 patch tested patients (18.3%) presented with eyelid dermatitis. Patients with eyelid dermatitis were more likely to be women compared to the non-eyelid group of patients. The two groups did not differ as for the frequency of atopy, including respiratory atopy and atopic dermatitis. The prevalence of ACD was statistically higher in the eyelid group (64.4%) compared to the non-eyelid group (49.4%). The most relevant allergens in patients with eyelid dermatitis were metals, preservatives and fragrances. Allergens resulting statistically more frequent in eyelid patients were methylchloroisothiazolinone/methylisothiazolinone, nickel sulphate, disperse blue 124, dimethylaminopropylamine. Conclusions. Patients with eyelid dermatitis are likely to have ACD, and need appropriate patch testing.
Introduction
Eyelid dermatitis is a common disorder and frequently difficult to interpret and treat. Different diseases can manifest in the eyelids including allergic contact dermatitis (ACD), atopic dermatitis (AD), irritant contact dermatitis, seborrheic dermatitis, psoriasis, rosacea, infections, and dermatomyositis (1, 2) . A number of studies have been conducted to determine the frequency of various skin disorders affecting the eyelids (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Although the results vary considerably, they were in agreement that ACD is the most frequent cause of periorbital dermatitis, with a prevalence ranging from 30% to as high as 77%. AD was the second most frequent cause followed by irritant contact dermatitis and seborrheic dermatitis. However, ACD may be overrepresented as almost all of the studies were conducted in tertiary referral centers where the patients were referred to for patch testing. The most frequent allergens found in previous studies to cause ACD were nickel, fragrance mix, balsam of Peru, methylchloroisothiazolinone/methylisothiazolinone, dermatophagoides (3, 4, 6, (9) (10) (11) (12) (13) , but also medicaments such as gentamicine, neomicine (7, 14) , ophthalmic products (especially thimerosal) (4, 9) and own products (5, 8) were found. The causes of ACD vary with time according to the changing use of substances in products contacting the skin. Therefore it is very important to update the list of contemporary allergens causing ACD. In addition, there is paucity of studies comparing the relevance of each single allergen in the eyelid dermatitis versus the non-eyelid dermatitis populations. Here we investigated a series of patients with eczematous eyelid dermatitis, comparing them with patients suffering of dermatitis in other body areas.
Methods
Between September 2012 and August 2014, a total of 1043 patients who presented with a clinical suspicion of ACD were patch tested in the Allergy Unit of the Section of Dermatology, University of Verona. All patients were registered about their age, sex, diagnosis, occupation, hobbies, personal history of atopy, (atopic dermatitis, asthma, allergic rhinitis), the location of their skin disease (eyelid and/or other sites). The onset of symptoms was measured in months. Palpebral manifestations were classified under the following categories: acute/subacute (duration of dermatitis less than 2 months) and chronic/chronic recurring (duration more than 2 months and/or recurring). @ C I C E d i z i o n i I n t e r n a z i o n a l i Patients suffering from palpebral eczematous dermatitis as well as psoriasis were included. Clinical manifestations were divided into the following categories: erithemato-desquamative, edematous, vesicular, papulosquamous, urticarial. The Finn chamber was used to perform patch test. The patch test chemicals were supplied by FIRMA SpA (Florence, Italy). The test chambers remained in place for 48 hours, with readings performed after 48 and 96 hours. Patch tests included the SIDAPA (Italian Society of Allergological Dermatology) series of haptens plus methylisothiazolinone 0.2%, carba mix 3%, imidazolidinyl urea 1%, propolis 20%, quinoline mix 6%, dimethylaminopropylamine 1%, desoximetasone 1%, hydrocortisone 17-butyrate 1%, methyl methacrylate 5%, gentamicin sulfate 25%, chlorhexidine digluconate 0.5%, and bronopol 0.2%. Patients with a suspicion of ACD to cosmetic products were also tested with their own products "as is" by using Finn Chambers in accordance with accepted concentrations and vehicles and using the Repeated Open Application Test (ROAT) (15) . Substances were applied on the flexor aspect of the forearm near the cubital fossa twice daily for 21 days unless dermatitis appeared earlier. Results regarding ophthalmic products are not shown due to paucity of results. Patch tests were scored according to the International Contact Dermatitis Research Group recommendations (16) . Readings were classified as negative, allergic, doubtful or irritant. Allergic reactions were evaluated as + (weak positive: erythema and infiltration), ++ (strong positive: erythema, infiltration, papules, vesicles), +++ (extreme positive: intense erythema, infiltration, coalescing vesicles). The relevance of each positive reaction was assessed based on past history of contact with the allergen and whether expressed symptoms were consistent with the clinical picture and history. Probable, possible, and certain relevance were pooled under "relevant" while past, unknown, and not applicable were considered as "non relevant". Only patients with positive and relevant reactions were considered to have ACD. On the basis of clinical findings and the final interpretation of patch test results, each patient was classified into one of the following diagnostic groups: ACD, AD, irritant contact dermatitis, seborrheic dermatitis, psoriasis, or other diseases. Irritant contact dermatitis was diagnosed when patients were found to have dermatitis at the site of contact with a substance that could be potentially irritant and if there were no relevant positive patch test results. AD was diagnosed based on the actual presence or history of the typical morphology and distribution of lesions, itching, and a chronic relapsing course (17) . Cases of psoriasis, AD or seborrheic dermatitis were tested if superimposed ACD was suspected. Statistical analysis was performed using the 21.0 Version of SPSS Software, using the chi-square test and the Fischer's exact test when the χ 2 test was deemed unreliable due to small expected values of <5%. A p value of 0.05 or less was considered to be statistically significant.
Results
One hundred and ninety one patients (18.3% of 1043 patch tested patients) presented with eyelid dermatitis, whereas the remaining 852 patients (81.7%) had dermatitis on other body areas. The vast majority of patients were female (77.6%); moreover, women in the eyelid group were statistically more frequent than women in the non-eyelid group (77 versus 65.5%, p=0.01) ( Table 1 ). Median age did not differ between two groups. However, 63% of patients with eyelid dermatitis were older than 40 years, indicating a higher prevalence of eyelid dermatitis in middle-to aged population. The most common occupation for both populations was office worker (25.6% in the eyelid group versus 16.7% in the non-eyelid group, p=0.001), followed by housewife/housekeeper (18.8 versus 17.9% respectively), student (16.2 versus 14.0%), retired (13.1 versus 14.2%), and workers, health worker, and waiters (<10% for both groups). The majority of patch tested patients (67.4%) did not have any history of atopy. The most frequent manifestation of atopy was asthma and/or rhinitis (18.8% of patients in the eyelid group and 21.3% in the non-eyelid). Twenty four patients of the eyelid group (12.6%) reported a history of AD, which was not significantly higher than the 
Discussion
In the present study 18.3% of 1043 patients patch tested over a 2-year period presented with eyelid dermatitis. This is in the upper range of published studies (3, (5) (6) (7) (12) (13) (14) , ranging from 3.9 to 18.0%. Compa rison with previous studies is often difficult especially because of different inclusion criteria of patients (eyelid and other body sites involved or exclusive palpebral involvement). The vast majority (77%) of eyelid dermatitis occurred in female patients and this is in accordance with previous studies (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Moreover, females in the eyelid group were more frequent than females in the non-eyelid dermatitis group, leading to the suspect that cosmetics may play a central role in the aetiology of palpebral dermatitis. Epidemiological studies conducted from 1999 to date have confirmed that female sex is a risk factor for developing eyelid dermatitis (5) . The majority (63%) of patients with eyelid dermatitis was older than 40 years. There was no difference between the age of patients with eyelid dermatitis and those with dermatitis elsewhere. The majority of both populations had a chronic/chronic recurring course as shown also by Ayala et al. (10) , although patients presenting with acute and oedematous lesions were more represented in the eyelid group. As in previous studies (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (18) (19) (20) , we found ACD to be the most frequent cause of eyelid dermatitis, occurring in 64.4% of patients. The frequency of ACD was higher in patients with exclusive palpebral involvement (74.1%), suggesting that a localized dermatitis should be more suspected to be ACD. This is in contrast with data reported by Amin & Belsito (7), reporting ACD being less frequent in patients with exclusive palpebral involvement respect to all patients with eyelid dermatitis. The second most frequent cause of eyelid dermatitis was irritant contact dermatitis (15.5%), followed by AD (11.3%). Similar ranking order was reported by Ayala et al. (10) , and Valsecchi et al. (13) . Differently, other Authors reported seborrheic dermatitis to be the second most frequent cause of eyelid dermatitis (ranging from 20.7 and 36.2%) (7, 12) . In our study seborrheic dermatitis accounted only for 6.8% of cases. It should be noted however that the sample in almost all of the studies was drawn from patients who were referred to tertiary referral clinics for patch testing. Therefore, these patients may not have been representative of the general population and making ACD overrepresented, because the patients who present with obvious rosacea, psoriasis, seborrheic dermatitis, or other easily diagnosed conditions are not likely to undergo patch testing. Moreover, it should be noted that 12.6% of patients presenting with eyelid dermatitis had AD, but of these only 1/4 of patients with palpebral involvement and AD resulted to have secondary ACD.
There is paucity of studies evaluating the role of each single allergen in ACD of the eyelid versus ACD affecting other body sites (7) . Metals (nickel sulphate, potassium dichromate, cobalt chloride) were most commonly involved. Despite being among the more common allergens in the non-eyelid dermatitis group, nickel sulphate demonstrated a higher prevalence among patients with eyelid dermatitis. In addition ACD due to cobalt chloride was found more frequent in patients with dermatitis localized to eyelid and other body sites when compared to patients with exclusive palpebral involvement (p=0.03). Most studies demon-@ C I C E d i z i o n i I n t e r n a z i o n a l i strated metals (especially nickel sulphate) as the leading allergens in eyelid dermatitis (3, 4, 6, 7, (9) (10) (11) (12) (13) (14) . The second most common allergen causing ACD in eyelid dermatitis was MCI/MI, which was found more frequent in patients with eyelid dermatitis (p=0.036) than in the non-eyelid dermatitis group. Also its component MI is the sixth most frequent allergen in the eyelid group. Moreover, MCI/MI was more frequent in patients with exclusive palpebral involvement. MI is used as a preservative in occupational and household products, and cosmetics. MCI/MI is one of the most frequent causes of preservative contact allergy and early studies showed that both MI and MCI are potent sensitizers. In the early 2000s, MI was released as an individual preservative for industrial products and, in 2005, it was permitted for use in cosmetic products. In the last years, MI has received increased attention owing to an alarming increase in the prevalence of Chlorhexidine digluconate 0.5% 0 (0) 0 (0) 0 (0) -Bronopol 0.2% 0 (0) 0 (0) 0 (0) -@ C I C E d i z i o n i I n t e r n a z i o n a l i contact allergy in different European countries (21) . The third group of leading allergens found was fragrances. Other studies have demonstrated fragrances to be common allergens in eyelid dermatitis (10, 13, 22) . Nine patients with eyelid dermatitis (4.7%) resulted to have ACD from dimethylaminopropylamine. This is a surfactant/emulsifier derived from cocamidopropyl betaine, found in numerous cosmetic products, that has been increasingly used in cosmetics and personal hygiene products. The prevalence was higher than the non-eyelid dermatitis group. Other Authors found also this allergen to be one of the most prevalent allergens for eyelid ACD (7) . About 3% of patients with eyelid dermatitis had ACD due to disperse blue 124 (an allergen commonly found in textile dyes) in contrast with only 0.7% of patients with non-eyelid dermatitis (p=0.012). None of the patients with eyelid dermatitis had ACD due to formaldehyde, which is in contrast with Herro et al., who reported formaldehyde to be the most frequently encountered allergen in a small series of patch tested patients with eyelid dermatitis (45.83%; 11/24) (23) . Nine patients had ACD to their own products, in all cases cosmetics, emphasizing the need in certain cases of the ROAT test. Feser et al. in 2008 reported the highest frequency of ACD due to own products, describing it in 31% of tested patients, and related to make up and ophthalmic products (5) .
In conclusion, ACD is an important causative factor in eyelid dermatitis, whether as a primary process or superimposed on a pre-existing condition, and also when the dermatitis has an exclusive palpebral involvement. Most common allergens were similar to those that are seen in general patch test population (metals, preservatives, fragrances), but some allergens resulted more frequent in eyelid patients (methylchloroisothiazolinone/methylisothiazolinone, nickel sulphate, disperse blue, dimethylaminopropylamine). Although eyelid dermatitis is challenging to diagnose and treat, with a thorough history and appropriate patch testing, an accurate diagnosis can be made and the patient properly managed. 
